TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
BMEA

Biomea Fusion Inc

Healthcare · Biotechnology

1.40$ -15.3% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow BMEA
Line item 2019 2020 2021 2022 2023 2024 2025
+1,550.0% +88.6% +177.5% +119.2% +15.4% -19.4%
+1,836.0% +65.8% +36.7% +35.1% -50.1%
+0.0% +1,571.3% +38.7%
-483.0% -69.6% -320.9%
+0.0% +6,117.6% -67.5% +227.2% -89.3% -100.0%
+0.0% +65,302.0% -108.1% -83.7%
-99.2%
+0.0% -200.0% -100.0%
+4,481.0% +132.2% -99.2% +13,120.2% -99.0% +3,971.0%
+38,071.4% +36.7% -140.3% -282.5%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?